Gyermekkori daganatok: vizsgálatok itt: Kanada
154 trials · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.
- 4. fázisTaking peopleDabrafenib and/or Trametinib Rollover Study
- Where
- Toronto
- Életkor
- 18 év to 100 év
- People
- 100 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT03340506 · EU 2023-509318-13-00 - 2. fázisTaking peopleBelzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
- Where
- Calgary, Toronto
- Életkor
- 12 év and over
- People
- 355 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT04924075 · EU 2023-504853-11-00 - 3. fázisTaking peopleStudy of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)
- Where
- Hamilton, London, Montreal, Ste-Foy, Toronto
- Életkor
- 15 év and over
- People
- 800 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06079671 · EU 2023-504374-38-00 - 2. fázisTaking peopleStudy to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
- Where
- Edmonton, Montreal
- Életkor
- 1 év to 18 év
- People
- 50 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07354074 - 2/3. fázisTaking peopleA Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)
- Where
- Toronto
- Életkor
- 12 év and over
- People
- 340 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07570173 · EU 2025-522267-15-00 - 4. fázisTaking peopleAsciminib Roll-over Study
- Where
- Montreal
- Életkor
- 7 év to 100 év
- People
- 347 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04877522 · EU 2023-507557-16-00 - No phaseTaking peoplePediatric Orthopaedic Implant Safety & Efficacy
- Where
- Vancouver
- Életkor
- 0 év to 25 év
- People
- 4000
- Run by
- University of British Columbia
See details and how to joinNCT05361980 - 1/2. fázisTaking peopleA Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
- Where
- Edmonton, Ottawa, Toronto, Vancouver
- Életkor
- 12 év and over
- People
- 840 worldwide
- Run by
- Nuvalent Inc.
See details and how to joinNCT05384626 · EU 2024-514266-39-00 - 3. fázisTaking peopleA Rollover Study for Participants Previously Enrolled in a Genentech and/or F. Hoffman-La Roche Sponsored Study
- Where
- Toronto
- People
- 200 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT05862285 · EU 2023-504263-16-00 - 3. fázisTaking peopleA Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
- Where
- Calgary, Edmonton, Halifax, Hamilton, London, Montreal, Ottawa, Québec, Saskatoon, Sherbrooke, Toronto, Vancouver, Winnipeg
- Életkor
- 5 év to 60 év
- People
- 1875 worldwide
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05675410 - 1/2. fázisTaking peopleStudy of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma
- Where
- Toronto
- Életkor
- 2 év to 30 év
- People
- 60 worldwide
- Run by
- Jazz Pharmaceuticals
See details and how to joinNCT05734066 - 1/2. fázisTaking peopleA Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)
- Where
- Montreal, Toronto, Vancouver
- Életkor
- 2 év and over
- People
- 420 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT04811560 · EU 2023-506581-31-00 - No phaseNot yet taking people in KanadaPositioning in RT - Supine vs. Upright
- Where
- Toronto
- Életkor
- 3 év and over
- People
- 105
- Run by
- University Health Network, Toronto
See details and how to joinNCT07765069 - 2/3. fázisTaking peopleLong-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
- Where
- Calgary, Hamilton, Montreal, Toronto, Vancouver
- People
- 1541 worldwide
- Run by
- Celgene
See details and how to joinNCT03435796 · EU 2023-504201-36-00 - Korai 1. fázisTaking peoplePilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation
- Where
- Calgary, Edmonton, Halifax, Hamilton, London, Montreal, Ottawa, Québec, Sherbrooke, Toronto, Vancouver, Winnipeg
- Életkor
- Up to 6 év
- People
- 15
- Run by
- C17 Council
See details and how to joinNCT06942039 - 3. fázisTaking peopleDinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
- Where
- Calgary, Edmonton, Halifax, Hamilton, London, Montreal, Ottawa, Québec, Saskatoon, Sherbrooke, St. John's, Toronto, Vancouver, Winnipeg
- Életkor
- Up to 30 év
- People
- 478 worldwide
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06172296 - 1/2. fázisTaking peopleSubstudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Where
- Calgary, Montreal, Toronto
- Életkor
- 6 hónap to 25 év
- People
- 90 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06395103 · EU 2023-507178-41-00 - No phaseTaking peopleMet Non Small Cell Cancer Registry (MOMENT)
- Where
- Ottawa, Québec, Toronto, Vancouver
- People
- 700 worldwide
- Run by
- EMD Serono Research & Development Institute, Inc.
See details and how to joinNCT05376891 - 2. fázisNot yet taking people in KanadaAdaptive Radiotherapy for Safe Hypofractionation
- Where
- Montreal
- People
- 264
- Run by
- Centre hospitalier de l'Université de Montréal (CHUM)
See details and how to joinNCT07516210 - 1. fázisTaking peopleStudy of Lunresertib Alone or in Combination With RP-3500 or Zedoresertib (Debio 0123) in Patients With Advanced Solid Tumors
- Where
- Montreal, Toronto
- Életkor
- 12 év and over
- People
- 464 worldwide
- Run by
- Debiopharm International SA
See details and how to joinNCT04855656 · EU 2023-510063-35-00 - No phaseTaking peopleCollection of Tissue Samples for Cancer Research
- Where
- Toronto
- Életkor
- 2 hónap and over
- People
- 5000 worldwide
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT00900198 - 2. fázisTaking peopleA Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
- Where
- Calgary, Edmonton, Halifax, Hamilton, Montreal, Québec, Sherbrooke, Toronto, Vancouver, Winnipeg
- Életkor
- 366 nap to 46 év
- People
- 222 worldwide
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06124157 - 2. fázisTaking peopleACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
- Where
- Montreal, Toronto
- Életkor
- 12 hónap to 39 év
- People
- 60 worldwide
- Run by
- Nationwide Children's Hospital
See details and how to joinNCT06838676 - 1/2. fázisTaking peopleStudy of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
- Where
- Montreal, Toronto
- Életkor
- 16 év and over
- People
- 85 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07155226 · EU 2025-521299-76-00 - 3. fázisTaking peopleStudy of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
- Where
- London, Montreal, Toronto
- Életkor
- 12 év and over
- People
- 468 worldwide
- Run by
- Syndax Pharmaceuticals
See details and how to joinNCT07211958 · EU 2025-522279-27-00